» Articles » PMID: 33755897

Prevalence and 11-year Incidence of Common Eye Diseases and Their Relation to Health-related Quality of Life, Mental Health, and Visual Impairment

Overview
Journal Qual Life Res
Date 2021 Mar 23
PMID 33755897
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To study the prevalence and incidence of the most common eye diseases and their relation to health-related quality of life (HRQoL), depression, psychological distress, and visual impairment in the aging population of Finland.

Methods: Our study was based on two nationwide health surveys conducted in 2000 and 2011. Eye disease status data were obtained from 7379 and 5710 individuals aged 30 + years, of whom 4620 partook in both time points. Both surveys included identical indicators of HRQoL (EuroQol-5 Dimension [EQ-5D], 15D), depression (Beck Depression Inventory [BDI]), psychological distress (General Health Questionnaire-12 [GHQ-12]), visual acuity, and self-reported eye diseases. We assessed the impact of known eye diseases on these factors, adjusted for age, gender, and co-morbidities.

Results: Prevalence of self-reported eye diseases was 3.1/2.7% for glaucoma, 8.1/11.4% for cataract, and 3.4/3.8% for retinal degeneration in 2000 and 2011, and the average incidence between 2000 and 2011 was 22, 109, and 35 /year/10,000 individuals, respectively. These eye diseases were associated with a significant decrease in EQ-5D and 15D index scores in both time points. BDI and GHQ-12 scores were also worsened, with some variation between different eye diseases. Impaired vision was, however, the strongest determinant of declined HRQoL. During the 11-year follow-up the effect of eye diseases on HRQoL and mental health diminished.

Conclusion: Declined HRQoL associated with eye diseases is more related to impaired vision than the awareness of the disease itself, and this declining effect diminished during the follow-up. Therefore, information directed to the public on the risks and prevention of blindness can and should be strengthened to prevent the deleterious effects of visual impairment.

Citing Articles

The effect of low vision rehabilitation on the quality of life and caregiver burden of low vision patients - a randomized trial.

Cai C, Shuai Y, Li G BMC Ophthalmol. 2025; 25(1):20.

PMID: 39815249 PMC: 11734459. DOI: 10.1186/s12886-025-03864-9.


Targeting ocular tissues with intravenously administered aptamers selected by SELEX.

Korhonen S, Stenberg K, Seemab U, Bartos P, Makiniemi K, Kjems J Mol Ther Nucleic Acids. 2024; 35(4):102352.

PMID: 39469668 PMC: 11513532. DOI: 10.1016/j.omtn.2024.102352.


Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021-2030): a societal perspective.

Pablo L, Garay-Aramburu G, Garcia Layana A, Fernandez A, Vazquez I, Acebes X Health Econ Rev. 2024; 14(1):70.

PMID: 39225974 PMC: 11370269. DOI: 10.1186/s13561-024-00546-y.


Health-related quality of life in patients with neovascular age-related macular degeneration: a prospective cohort study.

Kubin A, Korva-Gurung I, Ohtonen P, Hautala N J Patient Rep Outcomes. 2024; 8(1):89.

PMID: 39133415 PMC: 11319536. DOI: 10.1186/s41687-024-00775-z.


Diagnostic performance of light reflex pupillometry in Alzheimer's disease.

Gramkow M, Clemmensen F, Sjaelland N, Waldemar G, Hasselbalch S, Frederiksen K Alzheimers Dement (Amst). 2024; 16(3):e12628.

PMID: 39086497 PMC: 11289725. DOI: 10.1002/dad2.12628.


References
1.
Wang S, Singh K, Lin S . Prevalence and predictors of depression among participants with glaucoma in a nationally representative population sample. Am J Ophthalmol. 2012; 154(3):436-444.e2. PMC: 3422443. DOI: 10.1016/j.ajo.2012.03.039. View

2.
Walters S, Brazier J . Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005; 14(6):1523-32. DOI: 10.1007/s11136-004-7713-0. View

3.
Wolfram C, Lorenz K, Breitscheidel L, Verboven Y, Pfeiffer N . Health- and vision-related quality of life in patients with ocular hypertension or primary open-angle glaucoma. Ophthalmologica. 2013; 229(4):227-34. DOI: 10.1159/000350553. View

4.
Taipale J, Mikhailova A, Ojamo M, Nattinen J, Vaatainen S, Gissler M . Low vision status and declining vision decrease Health-Related Quality of Life: Results from a nationwide 11-year follow-up study. Qual Life Res. 2019; 28(12):3225-3236. PMC: 6863947. DOI: 10.1007/s11136-019-02260-3. View

5.
Finger R, Fenwick E, Marella M, Dirani M, Holz F, Chiang P . The impact of vision impairment on vision-specific quality of life in Germany. Invest Ophthalmol Vis Sci. 2011; 52(6):3613-9. DOI: 10.1167/iovs.10-7127. View